v3.25.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses        
Research and development $ 3,724,755 $ 5,584,347 $ 7,838,292 $ 11,368,212
General and administrative 2,348,227 2,545,296 4,772,857 4,683,537
Total operating expenses 6,072,982 8,129,643 12,611,149 16,051,749
Loss from operations (6,072,982) (8,129,643) (12,611,149) (16,051,749)
Other income (expense)        
Gain on remeasurement of warrant liabilities 11,126 200,273 72,320 656,450
Interest expense (4,797) (5,153) (16,417) (8,640)
Interest income 22,847 87,610 108,958 260,708
Other expense, net (1,850) (5,621) (26,995) (135,515)
Total other income, net 27,326 277,109 137,866 773,003
Loss before provision for income taxes (6,045,656) (7,852,534) (12,473,283) (15,278,746)
Provision for income taxes 7,954 7,385 13,167 14,781
Net loss $ (6,053,610) $ (7,859,919) $ (12,486,450) $ (15,293,527)
Net loss per share:        
Basic and diluted (in dollars per share) $ (0.12) $ (0.26) $ (0.25) $ (0.51)
Weighted average shares outstanding        
Basic and diluted (in shares) 49,847,872 30,555,012 49,249,430 30,221,168